Welcome to our dedicated page for Pure Bioscience news (Ticker: PURE), a resource for investors and traders seeking the latest updates and insights on Pure Bioscience stock.
PURE Bioscience (symbol: PURE) is a pioneering company based in El Cajon, California, specializing in the development and marketing of technology-based bioscience products aimed at addressing global health challenges. At the heart of PURE's innovation is its proprietary silver dihydrogen citrate (SDC)-based antimicrobials. These products stand out in the market due to their high efficacy and low toxicity, setting a new standard for both industry and consumer applications in 'green' products.
PURE's SDC technology is a patented, electrolytically generated source of stabilized ionic silver, offering substantial benefits over competitors. The technology's key advantages include superior efficacy, reduced toxicity, and a unique resistance-proof profile, ensuring that bacteria cannot develop resistance against it. These attributes make SDC an ideal candidate for integration with various compounds, providing versatile solutions across multiple sectors.
The company's commitment to innovation and safety has led to significant strides in diverse markets. PURE's products are designed to meet the rising demand for environmentally friendly and effective health solutions, providing competitive advantages in terms of both efficacy and safety.
As a recognized leader in bioscience technologies, PURE Bioscience continues to push the envelope with its cutting-edge research and development initiatives. The company's recent achievements, ongoing projects, and strategic partnerships underscore its dedication to enhancing global health through science and technology.
For more information about PURE Bioscience and its groundbreaking products, visit their official website at www.purebio.com.
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with Hydrite Chemical Company for the purchase and selling of SDC (silver dihydrogen citrate) products. The partnership builds upon an eight-year relationship between the companies and aims to expand the reach of PURE's antimicrobial technology through Hydrite's established distribution network.
The SDC technology works through a dual-action mechanism: silver ions deactivate structural and metabolic membrane proteins while also entering microbes as a perceived food source to denature DNA, preventing replication. Unlike traditional silver-based disinfectants with short shelf lives, SDC remains stable for several years. The agreement positions PURE to strengthen its market presence while enhancing Hydrite's product portfolio in food processing and other markets.
PURE Bioscience (OTCQB: PURE), developer of patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, has launched a comprehensive rebranding campaign in collaboration with Greenville (bbG). The initiative aims to reinforce the company's market presence and reflect its dedication to advancing antimicrobial and disinfection solutions for the food and beverage industry.
The new brand identity features a minimalist logo combining a wordmark with a molecular-inspired icon, representing the SDC molecule through three interconnected circles that also form a 'p' shape. The rebranding effort, led by bbG, includes a cohesive visual identity and messaging framework aligned with PURE's long-term objectives and commitment to innovation in cleaning and disinfection solutions.
PURE Bioscience (OTCQB: PURE) reported financial results for fiscal Q1 2025 ended October 31, 2024. Net product sales decreased to $555,000 from $718,000 in the same quarter last year, primarily due to budgetary constraints of a major customer. The company's net loss improved slightly to $689,000 compared to $735,000 in Q1 2024. Net loss per share remained stable at ($0.01).
CEO Robert Bartlett noted that while the company continues to develop its business strategy with key distributors, the process is taking longer than expected. PURE is investing resources in onboarding new distributors, training, and marketing initiatives to expand their product offerings across the food and beverage industry.
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with AFCO, a Zep Company, for their patented SDC (silver dihydrogen citrate) antimicrobial products. The strategic partnership aims to leverage AFCO's extensive network in the food and beverage sector. SDC technology offers a dual-action antimicrobial solution with a unique shelf life of several years, unlike traditional silver-based disinfectants that last only hours to days. The collaboration focuses on expanding product applications and providing innovative solutions throughout North America.
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with Quip Laboratories for its patented SDC (silver dihydrogen citrate) antimicrobial products. The partnership aims to enhance product accessibility across biomedical research, pharmaceutical production, companion animal care, and food processing industries. SDC's dual-action antimicrobial technology works by deactivating membrane proteins and denaturing DNA in microbes, offering a stable shelf life of several years compared to traditional silver-based disinfectants.
PURE Bioscience (OTCQB: PURE) reported fiscal year 2024 results with net product sales of $1.955M, up from $1.871M in 2023. The company reduced its net loss to $3.4M from $3.9M year-over-year, with net loss per share improving to ($0.03) from ($0.04). Cash used in operations decreased to $2.5M from $3.3M. During Q2 2024, PURE shifted its strategy from end-use customers to a distribution model, establishing multiple distributor partnerships across the US. The company is developing new Clean-in-Place solutions and focusing on innovation in food safety through collaborations with academia and distribution network scientists.
PURE Bioscience, Inc. (OTCQB: PURE) has entered into a multi-year distribution agreement with Madison Chemical Co., Inc. for the purchase and selling of SDC (silver dihydrogen citrate) products. This strategic partnership aims to expand the availability of PURE's innovative antimicrobial solutions in the food processing industry.
Tim Steffensmeier, VP of Sales at PURE, expressed excitement about the collaboration, highlighting Madison Chemical's expertise and loyal customer base as key factors in enhancing PURE's distribution capabilities. Andrew Sims, VP of Sales at Madison Chemical, emphasized the partnership's potential to leverage industry knowledge and meet growing demands in food processing.
The press release also explains how SDC works, noting its dual action mechanism that makes it highly effective against a broad spectrum of microbes. Unlike traditional silver-based disinfectants with short shelf lives, SDC offers a stable solution with a shelf life of several years.
PURE Bioscience, Inc. (OTCQB: PURE) has entered into a multi-year distribution agreement with Tennessee-based Zee Company to purchase and sell PURE's patented antimicrobial products. This partnership allows PURE, the creator of non-toxic Silver Dihydrogen Citrate (SDC) antimicrobials, to sell its products to Zee Company and its clients under special terms.
Zee Company, a member of the Vincit Group, brings over 50 years of expertise in chemical blending, laboratory services, food safety, and cleaning practices. The collaboration aims to deliver exceptional value and set new industry standards in the food and beverage sector.
PURE's SDC technology offers a dual-action antimicrobial solution that kills microorganisms by deactivating membrane proteins and denaturing DNA. Unlike traditional silver-based disinfectants with short shelf lives, SDC remains stable for several years, making it highly effective against a broad spectrum of microbes.
PURE Bioscience, Inc. (OTCQB: PURE) has entered into a multi-year distribution agreement with ChemStation Buyers Association, Inc. for the purchase and selling of SDC (silver dihydrogen citrate) products. This partnership aligns with ChemStation's commitment to delivering safe and effective custom cleaning solutions with environmental consideration.
SDC, PURE's patented non-toxic antimicrobial, kills microorganisms through two modes of action: deactivating structural and metabolic membrane proteins and denaturing DNA within the microbe. This dual action makes SDC highly effective against a broad spectrum of microbes. Unlike traditional silver-based disinfectants with short shelf lives, SDC remains stable for several years, offering a unique advantage in the antimicrobial market.
PURE Bioscience will unveil its newest food safety solutions at the 2024 International Association for Food Protection (IAFP) show in Long Beach, California, from July 14th-17th, 2024. The company specializes in non-toxic, chlorine-free food safety products using its patented silver dihydrogen citrate (SDC) molecule. Key products include PURE® Hard Surface, a disinfectant that eliminates bacteria like Listeria and E. coli in 30 seconds, and PURE Control®, an antimicrobial aid for produce and poultry. The event will feature various solutions aimed at improving food safety and sanitation without harmful chemicals.
FAQ
What is the current stock price of Pure Bioscience (PURE)?
What is the market cap of Pure Bioscience (PURE)?
What is PURE Bioscience's main product?
Where is PURE Bioscience headquartered?
What makes PURE's SDC technology unique?
What are the benefits of PURE's SDC technology?
What markets does PURE Bioscience serve?
How does PURE contribute to global health?
How can I learn more about PURE Bioscience's products?
What recent achievements has PURE Bioscience made?
Does PURE Bioscience have any strategic partnerships?
What is the search intent for PURE Bioscience's updates and news?
